This is how far researchers worldwide have come in fighting ASF

Published 2022년 5월 10일

Tridge summary

Kenya and Vietnam are leading the development of a vaccine against African swine fever (ASF), using modern technologies like CRISPR to accelerate the process. Kenya has identified vaccine candidates in under a year, while Vietnam is breeding pigs to produce antibodies against the virus, with expectations to have the vaccine by Q3 2021. In England, a new vaccine has been developed that provides 100% safety and can differentiate between infected and vaccinated pigs. An Icelandic team has created a genetic test to detect the ASF virus in pigs and products, aiding in the detection of the virus in imported goods. China has also developed an effective vaccine, and US scientists are working on an experimental vaccine.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

March 4, 2021: Kenya tests vaccine candidates against African swine fever A leading research institute in Kenya has started initial trials to test the effectiveness of a vaccine candidate against African swine fever (ASF). The key to controlling ASF is developing an effective vaccine against the disease, said Lucilla Steinaa of the International Livestock Research Institute (ILRI) in Nairobi. As early as the end of 2020, the ILRI announced that the most modern technology would be used for the development. The researchers are using the CRISPR gene scissors to accelerate the development of a live vaccine. Using CRISPR, ILRI scientists identified vaccine candidates in just over a year, while older techniques may have taken five years to reach the same level. The search for a vaccine against African swine fever continues in China as well. As the Chinese news agency Xinhua reported, testing of a total of ten vaccine candidates has started. The effectiveness against the virus genotype, ...
Source: Agrarheute

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.